孟鲁司特治疗特应性皮炎研究进展

China Journal of Leprosy and Skin Diseases ›› 2017, Vol. 33 ›› Issue (12): 759-762.

Previous Articles

Update of montelukast in atopic dermatitis

MENG Congcong, WNAG Xiaoqin, HAN Xiuping.

The Sheng Jing Hospital of China Medical University, Shenyang 110004, China

Online:2017-12-15 Published:2018-12-13
Contact: HAN Xiuping, E-mail: hanxiuping66@126.com

Abstract

MENG Congcong, WNAG Xiaoqin, HAN Xiuping.. Update of montelukast in atopic dermatitis[J].China Journal of Leprosy and Skin Diseases, 2017, 33(12): 759-762.

[1]	WU Zhe, YAO Zhirong. Update of skin microbiome of common skin diseases in infant [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(3): 185-188.
[2]	HAN Yue, YAO Xu. Activation and inflammation of HaCaT Cells regulated by exosomes in peripheral blood of the patients with atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 70-74.
[3]	YANG Yan, CHEN Quan, LIU Yumei, ZHOU Xin, TIAN Xin, GAO Aili, XIONG Siying, CHEN Xiaoyin, LI Wei, ZHU Huilan. Correlation between single nucleotide polymorphisms of IL-33/IL1RL1 genes and atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(11): 649-652.
[4]	ZHU Chenxi, YAO Zhirong. Update of the role of langerhans cell in the immune mechanism and treatment in atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(10): 631-635.
[5]	CHEN Zhongxiang, SHEN Zhengyu. Correlation between dietary and environmental factors with atopic dermatitis in children [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(1): 53-57.
[6]	HAN Yue, YAO Xu. Bioinformatics analysis of differentially expressed microRNAs in children with atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(9): 520-525.
[7]	WANG Zihong, BAI Bingxue. Research progress of thebiologicals for treating atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 445-448.
[8]	CHEN Jiawen, YAO Zhirong. Update of atopic dermatitis endotypes and targeted therapies [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(3): 184-188.
[9]	QIAN Jiali, HE Jingyan, SUN Liyun. Efficacy and safety of three-times dose of Ebastine in the treatment of mild to moderate atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(2): 70-72.
[10]	ZHANG Yuan, WANG Huicong, YAN Min. Relationship between clinical severity of atopic dermatitis in children and the levels of vitamin D and total IgE [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(2): 86-88.
[11]	WANG Xiaopan, QUAN Chen, CHEN Lihong, ZHENG Jie. Effects of linoleic acid-ceramide-containing moisturizer on atopic dermatitis mouse model [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(11): 647-650.
[12]	GAO Yingxia, CAO Chunyan. Intervention study about the Diversified Health Education based on ARNE Project in children with atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(10): 611-614.
[13]	WU Yuanyuan, ZHENG Jie, XIAO Fengli. Keratinocytes and atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(1): 54-56.
[14]	WANG Qian, LIU Wei, XUE Jing, WANG Qin, ZHANG Lixia. Expression of interleukin-35 in atopic dermatitis-like murine model [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 453-456.
[15]	LAN Yuzhen, MU Zhanglei , ZHAO Yan, ZHANG Jianzhong . Therapeutic effects of topical benvitimod in atopic dermatitis-like murine model [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 468-472.

Update of montelukast in atopic dermatitis

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10